OS

Oliver Stauch

Chief Operating Officer

Eyconis, Inc

San Francisco, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Eyconis, Inc
Industry
research
Employees
35.0
Seniority
C suite

Technologies

Outlook Amazon AWS Google Font API Mobile Friendly

Keywords

biotechnology research ophthalmology therapies eye disease treatment wet amd diabetic macular edema retinal vein occlusion geographic atrophy transcon technology long-acting therapeutics clinical development biopharmaceuticals patient adherence sustained-release delivery innovative drug development best-in-class therapies fda approval neovascular glaucoma vegf-a inhibitor diabetic retinopathy controlled release products therapeutic candidates high unmet medical need drug delivery innovations clinical trials safety & tolerability pharmaceutical manufacturing drug commercialization cutting-edge ophthalmology vision restoration biotech partnerships investor collaborations medical strategy global health authority approvals patient outcomes therapeutic pipeline personalized medicine regulatory challenges research & development medical innovation clinical efficacy vision loss prevention novel drug candidates cross-functional leadership stakeholder value lifesciences investments healthcare advancements retinal disease solutions biologics development drug formulation health care health wellness & fitness hospital & health care pharmaceuticals medical

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans